Streetbeat News

Stock Prices

HUDA

Hudson Acquisition I Corp. (NASDAQ:HUDA) has received a delisting notification from Nasdaq due to noncompliance with continued listing requirements. The company must appeal this decision to avoid delisting.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:08 pm

CMCSA

GOOG

GOOGL

Al Michaels will be featured as an AI-generated version of himself for Comcast's coverage of the 2024 Summer Olympics on Peacock. Google, through its Gemini AI, will partner with Team USA and Comcast to enhance Olympic coverage with advanced search and AI features.

Portfolio Pulse from Chris Katje

July 26, 2024 | 8:08 pm

SEEL

Seelos Therapeutics has announced that the Nasdaq Panel has granted their request for an additional period to regain compliance with Rule 5550(b)(2), allowing the company to remain listed on Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:05 pm

NAMS

NewAmsterdam Pharma (NASDAQ:NAMS) will report topline data from its Phase 3 BROOKLYN clinical trial evaluating Obicetrapib in patients with heterozygous familial hypercholesterolemia on July 29, 2024.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:02 pm

DAVE

Over the past three months, 10 analysts have evaluated Dave (NASDAQ:DAVE), with a mix of bullish and somewhat bullish ratings. The average 12-month price target has increased to $62.2, with a high of $75.00 and a low of $45.00. Dave has shown strong financial performance with significant revenue growth, high net margin, ROE, and ROA, and a prudent debt management strategy.

Portfolio Pulse from Benzinga Insights

July 26, 2024 | 8:02 pm

LUXH

LuxUrban Hotels Inc. (NASDAQ:LUXH) has announced a proposed follow-on public offering of its common stock. The company has not disclosed the size or amount of the offering. Additionally, LuxUrban intends to grant underwriters a 45-day option to purchase up to an additional 15% of the shares sold in the offering.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:02 pm

VTVT

Trading for VTV Therapeutics (VTVT) was halted at 4:01:47 p.m. ET due to pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:01 pm

UHS

Over the past three months, 15 analysts have shared their evaluations of Universal Health Services (NYSE:UHS), with ratings ranging from bullish to bearish. The average 12-month price target has increased to $197.27, with a high estimate of $256.00 and a low estimate of $162.00. Analysts have recently raised their price targets, reflecting positive sentiment towards the company's financial performance.

Portfolio Pulse from Benzinga Insights

July 26, 2024 | 8:01 pm

ALHC

Analysts have provided mixed ratings for Alignment Healthcare (NASDAQ:ALHC) in the latest quarter, with a notable increase in the average 12-month price target to $9.25. The company's financial performance shows strong revenue growth but challenges in profitability and debt management.

Portfolio Pulse from Benzinga Insights

July 26, 2024 | 8:01 pm

VKTX

Viking Therapeutics (NASDAQ:VKTX) has seen significant bullish options activity, with 46% of trades being bullish and 30% bearish. The stock price is currently up 2.5% at $66.3, with analysts setting an average target price of $104.33. Notable options trades include calls with strike prices ranging from $40 to $100.

Portfolio Pulse from Benzinga Insights

July 26, 2024 | 8:01 pm